Alongside the above models, the HepG2 cell line (a human hepatocellular carcinoma–derived hepatocyte model) is also widely used to study molecular mechanisms relevant to obesity and related disorders—ranging from lipid accumulation and insulin resistance to pharmacological effects of anti-obesity compounds. Here, INS is linked to hepatocellular carcinoma.